Anderson JL, Carlquist JF, Horne BD, Muhlestein JB. Cardiovascular pharmacogenomics: current status, future prospects. J Cardiovasc Pharmacol Ther. 2003;8(1):71-83.
Evans EE, McLeod HL. Pharmacogenomics—drug disposition, drug targets, and side effects. N Engl J Med. 2003;348:538-549.
Frequently asked questions about pharmacogenomics. National Human Genome Research Institute website. Available at: http://www.genome.gov/27530645. Updated February 14, 2014. Accessed April 6, 2016.
Mancama D, Kerwin RW. Role of pharmacogenomics in individualising treatment with SSRIs. CNS Drugs. 2003;17(3):143-151.
Pharmacogenomics. American Medical Association website. Available at: http://www.ama-assn.org/ama/pub/physician-resources/medical-science/genetics-molecular-medicine/current-topics/pharmacogenomics.page. Accessed April 6, 2016.
Pharmacogenetics fact sheet. National Institute of General Medical Sciences website. Available at: https://www.nigms.nih.gov/education/Pages/factsheet-pharmacogenomics.aspx. Updated March 2015. Accessed April 6, 2016.
Watters JW, McLeod HL. Cancer pharmacogenomics: current and future applications. Biochim Biophys Acta. 2003;1603(2):99-111.